Robotic Mitral Valve Surgery: A United States Multicenter Trial
In a prospective phase II Food and Drug Administration trial, robotic mitral valve repairs were performed in 112 patients at 10 centers by using the da Vinci surgical system.
World's Largest Resource for Cardiovascular Perfusion
In a prospective phase II Food and Drug Administration trial, robotic mitral valve repairs were performed in 112 patients at 10 centers by using the da Vinci surgical system.
Jeff Riley discusses observations from the Mayo Clinic regarding the new Heparin that is now on the market (17 minutes).
Unless we reprioritize the delivery of higher quality care at a reduced cost, robotic surgery will not deliver on its promises to better care for our patients.